A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/1997
11/04/1997	US5683986 Parenterally administering mismatched double stranded rna to a patient suffering from a herpes virus infection
11/04/1997	US5683985 Oligonucleotide decoys and methods relating thereto
11/04/1997	US5683902 Human papilloma virus inhibition by a hairpin ribozyme
11/04/1997	US5683873 EGS-mediated inactivation of target RNA
11/04/1997	US5683723 Nanoparticles based on a polyoxyethelene and polyactic acid block copolymer
11/04/1997	US5683716 Improved oral absorption of poorly soluble drugs
11/04/1997	US5683715 Taxane-containing phosphatidylcholine liposomes
11/04/1997	US5683713 Transdermal penetration for antioxidants of mercaptoacids, mercaptoesters and amides
11/04/1997	US5683711 Transdermal drug delivery of estrogen hormones
11/04/1997	US5683710 Percutaneous absorption preparation
11/04/1997	US5683709 Poly(benzalkonium salt) as an anti-microbial agent for aqueous drug compositions
11/04/1997	US5683705 Sulfur-based amides and bis-amides useful against skin disorders
11/04/1997	US5683693 Method for inducing T cell unresponsiveness to a tissue or organ graft with anti-CD40 ligand antibody or soluble CD40
11/04/1997	US5683685 Hair cosmetic composition
11/04/1997	US5683684 Use of sphingolipids in the preparation of a cosmetic or dermopharmaceutical composition protecting the skin and hair against the harmful effects of atmospheric pollution
11/04/1997	US5683682 Deodorants
11/04/1997	US5683676 Canister containing aerosol formulations containing P134a and particulate medicaments
11/04/1997	US5683675 Method of treating retained pulmonary secretions
11/04/1997	US5683151 Hydraulic unit for traction-controlled motor vehicle brake systems
11/04/1997	CA2089607C Nutritional supplement for the elderly
11/04/1997	CA2083698C (+)-alpha-(2,3-dimethoxyphenyl)-1- [2-(4-fluorophenyl) ethyl]-4-piperidinemethanol
11/04/1997	CA2025413C S-triazolo¬3,4-i\|purine derivatives
11/03/1997	CA2204082A1 Pharmaceutical compounds
10/1997
10/30/1997	WO1997040358A1 Markers for multidrug resistant cancers
10/30/1997	WO1997040187A1 Diagnostic method and apparatus
10/30/1997	WO1997040180A1 Chicken embryo lethal orphan (celo) virus
10/30/1997	WO1997040177A1 Method of stimulating an immune response by administration of host organisms that express intimin alone or as a fusion protein with one or more other antigens
10/30/1997	WO1997040176A1 Human monoclonal antibodies specific for hepatitis c virus (hcv) e2 antigen
10/30/1997	WO1997040166A2 Simian-human hav having a chimeric 2c protein
10/30/1997	WO1997040164A1 Hepatitis b monoclonal antibodies
10/30/1997	WO1997040163A1 Nucleic acid vaccination for parvoviral infections
10/30/1997	WO1997040161A1 Histidine-tagged intimin and methods of using intimin to stimulate an immune response and as an antigen carrier with targeting capability
10/30/1997	WO1997040152A1 Glial cell line-derived neurotrophic factor receptor
10/30/1997	WO1997040149A1 Autoantigen and proteins structurally related thereto for use in immunotherapy of autoimmune diseases
10/30/1997	WO1997040145A1 Inactivation resistant factor viii
10/30/1997	WO1997040142A1 Modified ligands of calcium-dependent binding proteins
10/30/1997	WO1997040134A2 Human dnase ii
10/30/1997	WO1997040073A2 BIOLOGICALLY ACTIVE PROTEIN (COLLAGEN FRAGMENT HF-COLL-18/514cf) FOR INHIBITING THE GROWTH OF TUMOURS AND CAPILLARY PROFILERATIONS
10/30/1997	WO1997040071A1 Compounds with growth hormone releasing properties
10/30/1997	WO1997040069A2 Secreted proteins and polynucleotides encoding them
10/30/1997	WO1997040068A1 Novel peptides suitable for use in antigen specific immunosuppressive therapy
10/30/1997	WO1997040066A1 Suppression of immune response via inhibition of cathepsin s
10/30/1997	WO1997040064A1 Human netrin-1
10/30/1997	WO1997040063A2 Pathogenic escherichia coli associated protein espa
10/30/1997	WO1997040062A1 Process for preparing steroids having a carboxamide side-chain
10/30/1997	WO1997040058A1 Flea protease proteins, nucleic acid molecules, and uses thereof
10/30/1997	WO1997040057A1 Antitumoral anthracycline disaccharides
10/30/1997	WO1997040050A1 Thienopyridine derivatives and their use
10/30/1997	WO1997040048A1 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
10/30/1997	WO1997040047A1 Preventives and remedies for ischemic intestinal lesion and ileus
10/30/1997	WO1997040046A1 Benzoquinolizine derivatives and medicinal compositions
10/30/1997	WO1997040045A1 Heterocyclic compounds and their preparation and use
10/30/1997	WO1997040044A1 Heterocyclic compounds
10/30/1997	WO1997040043A1 Heterocyclic compounds
10/30/1997	WO1997040042A1 Heterocyclic compounds
10/30/1997	WO1997040040A1 N-3 substituted pyrimidin-4-ones with aii antagonistic activity
10/30/1997	WO1997040038A1 Piperidines and pyrrolidines
10/30/1997	WO1997040037A1 Cycloalkylaminomethylpyrrolidine derivatives
10/30/1997	WO1997040036A1 Novel pyridonecarboxylic acid derivatives or salts thereof and antibacterial agents containing the same as the active ingredient
10/30/1997	WO1997040034A1 Solid phase and combinatorial synthesis of substituted thiophenes and of arrays of substituted thiophenes
10/30/1997	WO1997040033A1 Inhibition of the binding of human ige to its receptor by tetracyclic compounds for the alleviation of ige-mediated immune response
10/30/1997	WO1997040032A1 Chiral phenyldihydrofuranones as pde-iv inhibitors
10/30/1997	WO1997040031A1 Thiadiazolyl(thio)ureas useful as matrix metalloprotease inhibitors
10/30/1997	WO1997040029A1 Antivirally active heterocyclic azahexane derivatives
10/30/1997	WO1997040028A1 Urea derivatives as inhibitors of impdh enzyme
10/30/1997	WO1997040027A1 Substituted benzylamines and their use for the treatment of depression
10/30/1997	WO1997040024A1 Pyrazinone thrombin inhibitors
10/30/1997	WO1997040023A1 Compounds with growth hormone releasing properties
10/30/1997	WO1997040019A1 5-aminopyrazoles useful as selective inhibitors of the protein tyrosine kinase p56ick
10/30/1997	WO1997040017A2 Modulators of molecules with phosphotyrosine recognition units
10/30/1997	WO1997040016A1 Heterocyclic compounds
10/30/1997	WO1997040015A1 Tricyclic aminoalkylcarboxamides; novel dopamine d3 receptor subtype specific ligands
10/30/1997	WO1997040012A1 Pyridinyl-2-cyclopenten-1-ones as selective cyclooxygenase-2 inhibitors
10/30/1997	WO1997040011A1 Pharmaceutical compositions for prevention and treatment of central nervous system disorders
10/30/1997	WO1997040006A2 Phosphate mimics
10/30/1997	WO1997039768A1 A pharmaceutical formulation containing growth hormone, an amino acid and a non-ionic detergent
10/30/1997	WO1997039767A1 Methods for inducing bone formation
10/30/1997	WO1997039765A1 Component b as cicatrizant
10/30/1997	WO1997039760A1 Combination therapy for treatment of erectile dysfunction
10/30/1997	WO1997039759A2 Omega-3 fatty acids and omega-3 phosphatidylcholine in the treatment of bipolar disorder
10/30/1997	WO1997039758A1 Pharmaceutical compositions containing alkylaryl polyether alcohol polymer
10/30/1997	WO1997039756A1 Use of phosphonic acid esters for the treatment of functional disorders of the brain and depression
10/30/1997	WO1997039755A1 Oral pharmaceutical preparation containing ibandronat
10/30/1997	WO1997039754A1 Use of prostaglandins to treat ataxia telangiectasia
10/30/1997	WO1997039753A1 Heterocyclic compounds
10/30/1997	WO1997039752A1 Sertindole preparation and process for the production thereof
10/30/1997	WO1997039751A1 Compositions comprising a nitrone compound for use in treating ocular inflammation
10/30/1997	WO1997039750A1 Treatment of mood/affective disorders by glutamatergic upmodulators
10/30/1997	WO1997039749A2 Method for the prevention and treatment of cachexia and anorexia
10/30/1997	WO1997039748A1 Modulators of molecules with phosphotyrosine recognition units
10/30/1997	WO1997039747A1 Taste masked paracetamol compositions
10/30/1997	WO1997039746A1 Method of and composition for treating disorders of the skin using vitamin k
10/30/1997	WO1997039745A1 Use of inhaled retinoids in the prevention of cancer
10/30/1997	WO1997039744A1 Immediate release ph-independent solid dosage form of cisapride
10/30/1997	WO1997039743A1 Transdermal contraceptive delivery system
10/30/1997	WO1997039742A1 Transdermally administered dextromethorphan as antitussive agent
10/30/1997	WO1997039741A1 Transdermally administered acetylcysteine as mucolytic agent
10/30/1997	WO1997039734A1 Methods of regulating skin condition with centella asiatica extract
10/30/1997	WO1997039733A1 Methods of regulating skin appearance with vitamin b3 compound
10/30/1997	WO1997039729A1 Nsaid/fluoride periodontal compositions

1 ... 6730 6731 6732 6733 6734 6735 6736 6737 6738 6739 6740 6741 6742 6743 6744 6745 6746 6747 6748 6749 6750 ... 7860